To include your compound in the COVID-19 Resource Center, submit it here.

Tibotec, Pharmasset to test HCV combination

Pharmasset Inc. (NASDAQ:VRUS) partnered with Tibotec Pharmaceuticals Ltd. to evaluate a combination of two

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE